HER2-positive Breast Cancer
1 competing product in clinical development for HER2-positive Breast Cancer.
Pipeline by Phase
Phase 11
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| ALT-P7 (HM2-MMAE) | Alteogen | Phase 1 | Completed | 33 |
1 competing product in clinical development for HER2-positive Breast Cancer.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| ALT-P7 (HM2-MMAE) | Alteogen | Phase 1 | Completed | 33 |